Example: Heart Attack

Clinical Trials on Malaria, Vivax

Total 69 results

NCT04411836

Not yet recruiting

Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine

Conditions: Vivax Malaria, Plasmodium Vivax, Malaria, Vivax, Malaria Relapse
NCT00158587

Completed

Eight Week Primaquine Regimen for the Treatment of Vivax Malaria

Conditions: Malaria, Vivax Malaria
NCT00158561

Completed

Chlorproguanil/Dapsone Compared With Chloroquine and SP for Vivax Malaria

Conditions: Malaria, Vivax Malaria
NCT03307369

Completed

A Retrospective Study of Severe Plasmodium Vivax

Conditions: Malaria, Vivax
NCT02876549

Completed

G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria

Conditions: Vivax Malaria
NCT02563496

Completed

A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) Malaria

Conditions: Malaria, Vivax
NCT02802501

Completed

Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria

Conditions: Malaria, Vivax
NCT02696928

Withdrawn

Methylene Blue Against Vivax Malaria in Ethiopia

Conditions: Vivax Malaria
NCT02691910

Completed

Efficacy of Chloroquine (CQ) Alone Compared to Concomitant CQ and Primaquine for Plasmodium Vivax Infection

Conditions: Malaria, Vivax
NCT02751294

Completed

A Study to Assess the Effects of Dissolution Profile on the Pharmacokinetics of Single Oral Doses of Tafenoquine Tablets and Tafenoquine Stable Isotope Labelled Solution

Conditions: Malaria, Vivax
NCT03377296

Active, not recruiting

Study of Controlled Human Plasmodium Vivax Infection

Conditions: Malaria, Vivax
NCT02658435

Completed

Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)

Conditions: Malaria, Vivax
NCT04739917

Not yet recruiting

Efficacy of a Synthetic Vaccine Derived From Plasmodium Vivax Circumsporozoite Protein (PvCS) in naïve and Semi-immune Volunteers

Conditions: Malaria, Vivax
NCT04223674

Not yet recruiting

Serological Screen and Treat Trial for Plasmodium Vivax

Conditions: Malaria, Vivax
NCT04706130

Recruiting

Rigorous Assessment of P. Vivax Relapses and Primaquine Efficacy for Radical Cure

Conditions: Vivax Malaria
NCT03797989

Recruiting

VAC069: A Study of Blood-stage Controlled Human P. Vivax Infection

Conditions: Malaria, Vivax
NCT04201431

Recruiting

Safety, Immunogenicity and Efficacy of the Blood-stage Plasmodium Vivax Malaria Vaccine Candidate PvDBPII in Matrix M1

Conditions: Malaria, Vivax
NCT04009096

Recruiting

VAC071: A Study to Assess Efficacy of the ChAd63/MVA PvDBP Vaccines

Conditions: Malaria, Vivax
NCT02118090

Completed

Assessment of Plasmodium Vivax Chloroquine Resistance in Cambodia:

Conditions: Vivax Malaria
NCT02110784

Terminated

Eurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax Malaria

Conditions: Malaria, Vivax
NCT02184637

Completed

A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate

Conditions: Malaria, Vivax
NCT01928914

Completed

Tafenoquine Thorough QTc Study in Healthy Subjects

Conditions: Malaria, Vivax
NCT01716260

Completed

Safety and Efficacy of Chloroquine and Primaquine for Vivax Malaria in Bhutan

Conditions: Vivax Malaria
NCT01780753

Completed

Primaquine Pharmacokinetics in Lactating Women and Their Infants

Conditions: Vivax Malaria
NCT02216123

Completed

Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria

Conditions: Malaria, Vivax